Literature DB >> 12504541

Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating.

Isabelle Pelletier1, Laurent Ouzilou, Minetaro Arita, Akio Nomoto, Florence Colbère-Garapin.   

Abstract

A Sabin 1 strain poliovirus (PV) mutant, S1(2Y-1I), carrying a Tyr at amino acid position VP2(142) and an Ile at position VP1(160), can establish persistent infections in HEp-2c cells. This mutant forms atypical 147S particles upon interaction at 0 degrees C with either cells expressing PV receptor (PVR) CD155, or PVR-IgG2a, a chimeric molecule consisting of an extracellular moiety of PVR and the hinge and Fc portion of a mouse IgG2a. Upon interaction with PVR at 37 degrees C, S1(2Y-1I), similar to the parental strain, forms both 135S A particles and 80S empty capsids. At 0 degrees C, surprisingly, at a concentration equal to or greater than 5 nM, PVR-IgG2a induced both the extrusion of VP4 from the capsid of S1(2Y-1I) and the formation of 80S particles. The same transitions were observed at 0 degrees C with the parental strain Sabin 1 at 40 nM PVR-IgG2a. Thus, the formation of 80S particles and VP4 extrusion, considered as one of the steps of PV uncoating, can be temperature-independent at high PVR concentration. This implies that structural changes of the PV capsid occurred following adsorption at low temperature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12504541     DOI: 10.1006/viro.2002.1736

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Adenovirus protein VI mediates membrane disruption following capsid disassembly.

Authors:  Christopher M Wiethoff; Harald Wodrich; Larry Gerace; Glen R Nemerow
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.

Authors:  Maria L Yakovenko; Elena A Cherkasova; Gennady V Rezapkin; Olga E Ivanova; Alexander P Ivanov; Tatyana P Eremeeva; Olga Y Baykova; Konstantin M Chumakov; Vadim I Agol
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.